Core Viewpoint - The company announced that its wholly-owned subsidiary, Beijing Minhai Biotechnology Co., Ltd., has received a drug registration certificate from the National Medical Products Administration for the Sabin strain inactivated poliovirus vaccine (Vero cells), which is intended for the prevention of acute infectious diseases caused by poliovirus [1]. Group 1 - The drug registration certificate was issued by the National Medical Products Administration [1]. - The vaccine is specifically designed to prevent diseases caused by the poliovirus [1].